This is a demo store. No orders will be fulfilled.

AG14361, 聚(ADP-核糖)聚合酶 1 抑制剂

有货

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
A125467-5mg
5mg 现货 Stock Image
A125467-10mg
10mg 现货 Stock Image
A125467-50mg
50mg 现货 Stock Image

基本描述

英文别名 SCHEMBL476278 | DTXSID80186513 | AB03409 | HMS2210M16 | AKOS016347360 | J-507662 | 1-(4-((dimethylamino)methyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one | 1-(4-((dimethylamino)methyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-
规格或纯度 Moligand™, ≥98%
英文名称 AG14361
生化机理 据统计,AG14361在照射前处理可显著提高携带LoVo异种移植物的小鼠对放射治疗的敏感性。据统计,AG14361能明显增加异种移植物的血流量,从而有可能增加向肿瘤异种移植物输送drμg的量。
储存温度 -20°C储存
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 聚(ADP-核糖)聚合酶 1 抑制剂
产品介绍

AG14361是PARP1抑制剂,Ki<5 nM,比苯甲酰胺的抑制性强1000倍。

AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides.

纯度 ≥98%

关联靶点(人)

PARP1 Tclin 聚[ADP-核糖]聚合酶1(Poly [ADP-ribose] polymerase 1) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PARP1 Tclin Poly [ADP-ribose] polymerase-1 (6206 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
YES1 Tclin Tyrosine-protein kinase YES (2781 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
LoVo (4724 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
A549 (127892 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HepG2 (196354 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SMAD3 Tchem Mothers against decapentaplegic homolog 3 (68039 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
GMNN Tbio Geminin (128009 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

关联靶点(其它种属)

Hdac6 Histone deacetylase 6 (222 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
H9c2 (3506 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SARS-CoV-2 (38078 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

分子类型 小分子
IIUPAC Name 2-[4-[(dimethylamino)methyl]phenyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one
INCHI 1S/C19H20N4O/c1-22(2)12-13-6-8-14(9-7-13)18-21-16-5-3-4-15-17(16)23(18)11-10-20-19(15)24/h3-9H,10-12H2,1-2H3,(H,20,24)
InChi Key SEKJSSBJKFLZIT-UHFFFAOYSA-N
Smiles CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3N2CCNC4=O
Isomeric SMILES CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3N2CCNC4=O
分子量 320.4
Reaxy-Rn 9283091
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9283091&ln=

化学和物理性质

溶解性 DMSO ≥20mg/mL Water <1.2mg/mL Ethanol ≥11mg/mL
分子量 320.400 g/mol
XLogP3 1.900
氢键供体数Hydrogen Bond Donor Count 1
氢键受体数Hydrogen Bond Acceptor Count 3
可旋转键计数Rotatable Bond Count 3
精确质量Exact Mass 320.164 Da
单同位素质量Monoisotopic Mass 320.164 Da
拓扑极表面积Topological Polar Surface Area 50.200 Ų
重原子数Heavy Atom Count 24
形式电荷Formal Charge 0
复杂度Complexity 460.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 0
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 1

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
A1819016 分析证书 A125467
A1819015 分析证书 A125467
L1612070 分析证书 A125467

引用文献

1. Skalitzky DJ, Marakovits JT, Maegley KA, Ekker A, Yu XH, Hostomsky Z, Webber SE, Eastman BW, Almassy R, Li J et al..  (2003)  Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors..  J Med Chem,  46  (2): (210-3).  [PMID:12519059]
2. Veuger SJ, Curtin NJ, Richardson CJ, Smith GC, Durkacz BW.  (2003)  Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1..  Cancer Res,  63  (18): (6008-15).  [PMID:14522929]
3. Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canan-Koch S, Durkacz BW, Hostomsky Z, Kumpf RA, Kyle S et al..  (2004)  Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361..  J Natl Cancer Inst,  96  (1): (56-67).  [PMID:14709739]
4. Curtin NJ, Wang LZ, Yiakouvaki A, Kyle S, Arris CA, Canan-Koch S, Webber SE, Durkacz BW, Calvert HA, Hostomsky Z et al..  (2004)  Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells..  Clin Cancer Res,  10  (3): (881-9).  [PMID:14871963]
5. Smith LM, Willmore E, Austin CA, Curtin NJ.  (2005)  The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks..  Clin Cancer Res,  11  (23): (8449-57).  [PMID:16322308]
6. Buisson R, Dion-Côté AM, Coulombe Y, Launay H, Cai H, Stasiak AZ, Stasiak A, Xia B, Masson JY.  (2010)  Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination..  Nat Struct Mol Biol,  17  (10): (1247-54).  [PMID:20871615]
7. Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S, Pommier Y.  (2012)  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors..  Cancer Res,  72  (21): (5588-99).  [PMID:23118055]

溶液计算器